Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cells in space

J Wong

    Nature Medicine
    |March 1, 1997
    PubMed
    Summary
    This summary is machine-generated.

    NASA

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Association of Neisseria cinerea with ocular infections in paediatric patients.

    The Journal of infection·1998
    Same author

    Transcription from the thyroid hormone-dependent promoter of the Xenopus laevis thyroid hormone receptor betaA gene requires a novel upstream element and the initiator, but not a TATA Box.

    The Journal of biological chemistry·1998
    Same author

    Unique organization and involvement of GAGA factors in transcriptional regulation of the Xenopus stromelysin-3 gene.

    Nucleic acids research·1998
    Same author

    Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

    Genes & development·1998
    Same author

    The value of neck drain in esophageal surgery: a randomized trial.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·1998
    Same author

    Unusual features of the Drosophila melanogaster telomere transposable element HeT-A are conserved in Drosophila yakuba telomere elements.

    Proceedings of the National Academy of Sciences of the United States of America·1998
    Same journal

    Biological aging might help to explain the rising risk of early-onset cancer.

    Nature medicine·2026
    Same journal

    Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

    Nature medicine·2026
    Same journal

    A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.

    Nature medicine·2026
    Same journal

    Blood-based circular RNAs for early diagnosis of Alzheimer's disease.

    Nature medicine·2026
    Same journal

    Author Correction: Digital AVATAR therapy for distressing voices in psychosis: the phase 2/3 AVATAR2 trial.

    Nature medicine·2026
    Same journal

    Clinical decision support in hematological malignancies using a case-grounded AI agent.

    Nature medicine·2026
    See all related articles

    Area of Science:

    • Biotechnology
    • Space Medicine
    • Tissue Engineering

    Background:

    • NASA's rotating bioreactor cultivates cells in microgravity, minimizing shear forces.
    • This unique environment mimics embryonic development, enhancing cell differentiation and matrix formation.
    • Traditional methods were insufficient for culturing certain cells and viruses.

    Discussion:

    • The microgravity, low-shear environment promotes cell-to-cell contact and chemical signaling.
    • This mimics in vivo conditions, leading to cellular expression similar to intact tissues.
    • The bioreactor facilitates the growth of previously unculturable cells and viruses.

    Key Insights:

    • NASA's bioreactor enables the growth of cells and viruses difficult to culture on Earth.
    • It replicates conditions similar to embryogenesis, promoting tissue-like cellular behavior.
    • Enhanced cell signaling and surface epitope expression are observed.

    Outlook:

    • VivoRx licensed NASA's bioreactor for therapeutic and diagnostic applications.
    • The technology holds promise for generating sufficient human islet cells for diabetes treatment.
    • Clinical trials are underway for cell-based diabetes therapies.